Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Medicinal chemistry of antimigraine drugs.

Tekes K, Szegi P, Hashemi F, Laufer R, Kalász H, Siddiq A, Ertsey C.

Curr Med Chem. 2013;20(26):3300-16. Review.

PMID:
23746273
2.

Practical considerations for the treatment of elderly patients with migraine.

Sarchielli P, Mancini ML, Calabresi P.

Drugs Aging. 2006;23(6):461-89. Review.

PMID:
16872231
3.

Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.

Labruijere S, Ibrahimi K, Chan KY, Maassenvandenbrink A.

Expert Opin Drug Discov. 2013 Nov;8(11):1309-23. doi: 10.1517/17460441.2013.826644. Epub 2013 Aug 21. Review.

PMID:
23962310
4.

Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.

Tajti J, Szok D, Csáti A, Vécsei L.

Curr Pain Headache Rep. 2016 Jan;20(1):1. doi: 10.1007/s11916-015-0536-6. Review.

PMID:
26695061
5.

Management of migraine: an algorithmic approach.

Silberstein SD, Goadsby PJ, Lipton RB.

Neurology. 2000;55(9 Suppl 2):S46-52. Review.

PMID:
11089519
6.

Current and prospective pharmacological targets in relation to antimigraine action.

Mehrotra S, Gupta S, Chan KY, Villalón CM, Centurión D, Saxena PR, MaassenVanDenBrink A.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):371-94. doi: 10.1007/s00210-008-0322-7. Epub 2008 Jul 15. Review.

PMID:
18626630
7.

Migraine: pathophysiology, pharmacology, treatment and future trends.

Villalón CM, Centurión D, Valdivia LF, de Vries P, Saxena PR.

Curr Vasc Pharmacol. 2003 Mar;1(1):71-84. Review.

PMID:
15320857
8.

Migraine.

Edmeads JG.

CMAJ. 1988 Jan 15;138(2):107-13. Review.

9.

Migraine: current concepts and emerging therapies.

Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL.

Vascul Pharmacol. 2005 Sep;43(3):176-87. Review.

PMID:
16099727
10.

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.

Villalón CM, Olesen J.

Pharmacol Ther. 2009 Dec;124(3):309-23. doi: 10.1016/j.pharmthera.2009.09.003. Epub 2009 Sep 29. Review.

PMID:
19796656
11.

An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy.

Villalón CM, Centurión D, Valdivia LF, De Vries P, Saxena PR.

Proc West Pharmacol Soc. 2002;45:199-210. Review.

PMID:
12434581
12.

Emerging treatment for chronic migraine and refractory chronic migraine.

Lionetto L, Negro A, Palmisani S, Gentile G, Del Fiore MR, Mercieri M, Simmaco M, Smith T, Al-Kaisy A, Arcioni R, Martelletti P.

Expert Opin Emerg Drugs. 2012 Sep;17(3):393-406. doi: 10.1517/14728214.2012.709846. Epub 2012 Aug 3. Review.

PMID:
22862686
13.

The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors.

Gupta S, Villalón CM.

Pharmacol Ther. 2010 Oct;128(1):170-90. doi: 10.1016/j.pharmthera.2010.06.005. Epub 2010 Jul 22. Review.

PMID:
20655327
14.

[Faster, higher, further. Current thinking on acute and prophylactic treatment of migraine].

Limmroth V, Hubrecht L, Diener HC.

Schmerz. 2004 Oct;18(5):398-403. Review. German.

PMID:
15322886
15.

CGRP receptor antagonists: toward a novel migraine therapy.

Salvatore CA, Kane SA.

Curr Pharm Biotechnol. 2011 Oct;12(10):1671-80. Review.

PMID:
21466447
16.

Evidence-based medicine in migraine prevention.

Yoon MS, Savidou I, Diener HC, Limmroth V.

Expert Rev Neurother. 2005 May;5(3):333-41. Review.

PMID:
15938666
17.

Antimigraine drugs.

Diener HC, Kaube H, Limmroth V.

J Neurol. 1999 Jul;246(7):515-9. Review.

PMID:
10463349
18.

Advances in pharmacological treatment of migraine.

Diener HC, Limmroth V.

Expert Opin Investig Drugs. 2001 Oct;10(10):1831-45. Review.

PMID:
11772289
19.

Antimigraine drug consumption in Spain (1990-2000).

García-del-Pozo J, Carvajal A, Grajal C, Vera E, del Pino A.

Acta Neurol Scand. 2003 Feb;107(2):158-60.

PMID:
12580869
20.

[Managing the attacks, preventing headache. Migraine therapy in 2002].

Göbel H, Heinze A, Heinze-Kuhn K.

MMW Fortschr Med. 2002 May 6;Suppl 2:43-50. German.

PMID:
12070849

Supplemental Content

Support Center